Organizations like yours are familiar to us. We are chemists, engineers, molecular biologists, researchers, and scientists who combine our technical understanding with legal, regulatory, and compliance excellence to provide you with well-informed counsel – from your patent portfolio development, protection, and monetization strategies to market entry and exit strategies.
Whether you are an inventor, start-up, venture capitalist, investor, Fortune 50 or Fortune 500 company, or research institution we help people like you on all aspects of pharmaceuticals, biotechnology and medical devices. We understand that regulatory and compliance will dominate your thinking – and can help you meet your requirements on every issue from M&A to tax, HR and real estate.
We know that often in this industry, time is of the essence, and we are proud that we continually demonstrate that we can work at speed without compromising on efficiency. This is demonstrated by our looking at patents for potential vaccines and detection methods, as well as dealing with urgent approval for medical devices and personal protective equipment.
Whatever your background, we can help you commercialize your inventions, protect key intellectual property and structure your business and partnerships to best enable you to bring the next generation of medicines, products and services to market.
Some of our recent work includes:
- representing an US pharmaceutical company in the reorganization of its Austrian distribution organization
- advising a market-leading Austrian home nursing services provider on the organization and the standard agreements for its 24-hour care
- advising in unfair trade litigation regarding advertisement for drugs and medical devices
- advising life sciences companies on all issues of public procurement of medicinal products by hospitals and governmental agencies
- advising a pharmaceutical wholesaler on issues of the verification of the authenticity of medicinal products and related issues of data protection
Latest Insights
Latest News
- client newsEversheds Sutherland advises Costello Medical on transition to employee ownership
- firm newsStrengthening our life sciences and regulatory capability with key hire in Paris
- firm newsEversheds Sutherland Advises The Centurion Foundation on Completed Acquisition of Roger Williams Medical Center and Fatima Hospital
- client newsEversheds Sutherland advises on £5.2bn disposal of Barchester Healthcare
legal updates
June 09, 2026
EU Legislation Roundup: May 2026
legal updates
June 03, 2026
Global Life Sciences & Healthcare Bulletin
legal updates
April 28, 2026
The EDPB’s new scientific research guidelines: a welcome route map, but no ...
legal updates
April 14, 2026
Hong Kong: Open consultation on listing reforms
client news
July 09, 2026
Eversheds Sutherland advises Costello Medical on transition to employee own...
firm news
July 01, 2026
Strengthening our life sciences and regulatory capability with key hire in ...
firm news
March 20, 2026
Eversheds Sutherland Advises The Centurion Foundation on Completed Acquisit...
client news
November 06, 2025
Eversheds Sutherland advises on £5.2bn disposal of Barchester Healthcare